Innoveix Pharmaceuticals Inc
FDA Regulatory Profile
Summary
- Total Recalls
- 6
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-0693-2021 | Class II | Compounded Lyophilized AOD-9604, 3 mg For subcutaneous or intramuscular injection, Rx Only, Compound | July 9, 2021 |
| D-0692-2021 | Class II | Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection, Rx Onl | July 9, 2021 |
| D-0159-2020 | Class II | Lyophilized Sermorelin w/ GHRP2 3 mg For injection, Rx Only, Compounded by: Innoveix Addison, TX 750 | October 10, 2019 |
| D-0157-2020 | Class II | Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, Compounded by: Innoveix | October 10, 2019 |
| D-0158-2020 | Class II | Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx Only, Compounded by: Inno | October 10, 2019 |
| D-0160-2020 | Class II | Lyophilized Human Chorionic Gonadotropin 5,500 USP Units For injection, Rx Only, Compounded by: Inno | October 10, 2019 |